{"schema_version":"1","generated_at":"2026-11-17T16:51:41.514Z","data_as_of":null,"url":"https://www.findmykol.com/kol/eric-jurgens","json_url":"https://www.findmykol.com/kol/eric-jurgens/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"eric-jurgens","name":"Eric Jurgens","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Memorial Sloan Kettering Cancer Center","institution_url":"https://www.findmykol.com/institution/memorial-sloan-kettering-cancer-center","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1023571478","orcid":"0000-0001-8280-2581","openalex":"A5057582571"},"summary":"Eric Jurgens is an Oncology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 59 publications with 548 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":59,"cited_by_count":548,"h_index":11,"latest_activity_year":2026,"emerging":true,"source":"works"},"prescribing":{"data_year":2022,"areas_total":3,"areas_shown":3,"areas":[{"area":"Cardiovascular","share_pct":55.2,"classes_total":2,"classes":[{"class":"Calcium channel blocker","setting":"prescribed","share_pct":32.2,"drugs":[{"name":"Amlodipine Besylate","share_pct":100}],"max_beneficiaries":11},{"class":"Statin","setting":"prescribed","share_pct":23,"drugs":[{"name":"Atorvastatin Calcium","share_pct":100}],"max_beneficiaries":11}]},{"area":"Metabolism & gastrointestinal","share_pct":31,"classes_total":2,"classes":[{"class":"Biguanide (metformin)","setting":"prescribed","share_pct":17.2,"drugs":[{"name":"Metformin Hcl","share_pct":100}],"max_beneficiaries":null},{"class":"SGLT2 inhibitor","setting":"prescribed","share_pct":13.8,"drugs":[{"name":"Farxiga","share_pct":100}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":13.8,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":13.8,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM","year":2026,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025018537","status":"verified"},{"title":"Pharmacokinetics of CAR T cells in multiple myeloma – the good, the bad, and the ugly","year":2026,"journal":"Leukemia","source_url":"https://doi.org/10.1038/s41375-026-02933-2","status":"verified"},{"title":"Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma","year":2026,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-026-01494-y","status":"verified"},{"title":"Patient‐Specific Determinants of Response to BCMA ‐ and GPRC5D ‐Targeted CAR T‐Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real‐World Data","year":2026,"journal":"Clinical Pharmacology & Therapeutics","source_url":"https://doi.org/10.1002/cpt.70378","status":"verified"},{"title":"PA-133 Deep Generative Modeling of Multi-Cohort Flow Cytometry Reveals a T-Cell Exhaustion Signature Predictive of Post-ASCT Outcomes in Myeloma","year":2026,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(26)03501-9","status":"verified"}],"source":"works"},"contact":{"address_1":"1275 YORK AVE","city":"New York","state":"NY","zip":"100656007","phone":"212-639-2000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1023571478","source":"identity"},"similar":[{"name":"Marc Ladanyi","slug":"marc-ladanyi","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Anatomic Pathology","url":"https://www.findmykol.com/kol/marc-ladanyi","json_url":"https://www.findmykol.com/kol/marc-ladanyi/profile.json"},{"name":"Howard Scher","slug":"howard-scher","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/howard-scher","json_url":"https://www.findmykol.com/kol/howard-scher/profile.json"},{"name":"Robert Motzer","slug":"robert-motzer","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/robert-motzer","json_url":"https://www.findmykol.com/kol/robert-motzer/profile.json"},{"name":"Murray Brennan","slug":"murray-brennan","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/murray-brennan","json_url":"https://www.findmykol.com/kol/murray-brennan/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-04-29","provider_certified":"2025-04-29","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}